PIN36 COST-UTILITY OF PEGINTERFERON-ALFA-2A (40 KD) IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS B WITH AND WITHOUT THE “E” ANTIGEN IN BRAZIL
Abstract
Authors
H Sette R Parana M Pessoa D Crespo F Barros MG Saggia EA Santos R Simoes